Genome-guided treatment for advanced rare cancers
Part of Cancer clinical trials.
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a rare cancer that is advanced or has spread, and cannot be cured with standard treatments.
- Your cancer has gotten worse or is expected to get worse.
- You have at least one tumor that can be measured on a CT or MRI scan.
- You have already tried at least one standard treatment, or no standard treatment is available for your cancer.
- You can have a fresh biopsy of your tumor, or you have a frozen tumor sample taken within the last 3 months.
- You are in generally good health (ECOG performance status 0, 1, or 2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.
This trial looks at a more tailored way to choose treatment for people with rare cancers that have spread or grown locally and can’t be cured with standard therapies. The goal is to better target the tumor to improve the chance of tumor shrinkage or eradication.
This trial tests a personalized treatment approach for people with metastatic (advanced spread) breast cancer using tumor testing. It may help guide doctors toward better-matched therapies based on genomic (DNA) information from your tumor.
This study uses tumor genetic testing to help plan more precise treatment for people with early high-risk breast cancer. You may be asked to give a recent tumor sample so researchers can match your cancer features with the best available options.
This trial tests a personalized approach for people with rare advanced or metastatic solid tumors. Doctors use special lab tests on your tumor tissue and blood to find the best treatment for you.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
Hear when a new Rare Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.